Omnicef Related Published Studies
Well-designed clinical trials related to Omnicef (Cefdinir)
A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study. [2005.06]
Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study. [2004.12]
[Comparative study on cefdinir and cefaclor in the treatment of patients with mild to moderate bacterial community acquired pneumonia.] [2004.11.17]
Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media. [2004.09]
[Clinical efficacy and bacteriological studies of clarithromycin and cefdinir against group A beta-hemolytic streptococcal tonsillopharyngitis] [2003.08]
Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients. [2000.12]
Comparison of cefdinir and penicillin V in the treatment of pediatric streptococcal tonsillopharyngitis. [2000.12]
Cefdinir vs. amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children. [2000.12]
Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children. [2000.12]
Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection. [2000.07]
A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis. [2000.06]
Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis. [2000.06]
Efficacy and safety of cefdinir in the treatment of maxillary sinusitis. [2000]
International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis. [2000]
Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Cefdinir Pharyngitis Study Group. [1999.11]
Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitis. [1999.09]
Five-day cefdinir treatment for streptococcal pharyngitis. Cefdinir Pharyngitis Study Group. [1998.05]
Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group. [1998.03]
Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia. [1997.07]
Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group. [1997.07]
Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study Group. [1997.04]
Cefdinir versus amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children. [1997.03]
A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Cefdinir Pediatric Pharyngitis Study Group. [1997.01]
Efficacy and safety of cefdinir in the treatment of patients with acute bronchitis. The Cefdinir Bronchitis Study Group. [1996.07]
Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments. [1996.02]
Impairment of cefdinir absorption by iron ion. [1993.11]
Other research related to Omnicef (Cefdinir)
Rate of eradication of group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir. [2009.05]
Cefdinir-induced hepatotoxicity: potential hazards of inappropriate antibiotic use. [2008.11]
Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir. [2008.07.15]
Cefdinir-associated "bloody stools" in an infant. [2008.05]
Nonbloody, red stools from coadministration of cefdinir and iron-supplemented infant formulas. [2008.05]
Comparative bioavailability of two cefdinir suspension formulations in Middle Eastern healthy volunteers after single oral administration. [2008]
Effect of l-phenylalanine supplementation and a high-protein diet on pharmacokinetics of cefdinir in healthy volunteers: an exploratory study. [2007.06]
Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections. [2007.02]
Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults. [2006.12]
Therapeutic experience with cefdinir in the treatment of uSSSIs. [2006.10]
Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children. [2006.09]
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly? [2006.08]
The efficacy of cefdinir in acute bacterial rhinosinusitis. [2006.06]
A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection. [2006.03]
Cefdinir pharmacokinetics and tolerability in children receiving 25 mg/kg once daily. [2006.03]
A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years. [2005.12]
Recovery of interfering bacteria in the nasopharynx following antimicrobial therapy of acute maxillary sinusitis with telithromycin or amoxicillin-clavulanate. [2005.11]
Effects of amoxicillin and cefdinir on nasopharyngeal bacterial flora. [2005.09]
A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis. [2005.08]
Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxycillin-clavulanate. [2005.06]
Cefdinir: an oral alternative to parenteral cephems. [2005.04]
Overview of cefdinir: pharmacokinetics, safety, and efficacy in the treatment of uncomplicated skin and skin structure infections. [2004.05]
Parent-reported outcomes for treatment of acute otitis media with cefdinir or amoxicillin/clavulanate oral suspensions. [2004]
Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections. [2004]
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002). [2003.11]
Management update of acute bacterial rhinosinusitis and the use of cefdinir. [2002.12]
Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin. [2002.04]
Lack of interaction between cefdinir and calcium polycarbophil: in vitro and in vivo studies. [2002]
Comparison of once-daily versus twice-daily administration of cefdinir against typical bacterial respiratory tract pathogens. [2001.10]
Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure. [2001.02]
Cefdinir: an expanded-spectrum oral cephalosporin. [2000.12]
Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin. [2000.12]
Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan. [2000.11]
Two cases of confluent and reticulate papillomatosis: successful treatments of one case with cefdinir and another with minocycline. [2000.09]
Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis. [1998.08]
In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production. [1996.06]
Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for both microdilution and disc diffusion methods. [1995.11]
Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses. [1995.05]
Study on treatment of bacterial vaginosis with oral administration of metronidazole or cefdinir. [1994.09]
In vitro activity of two new oral cephalosporins, cefixime and cefdinir (CI 983), on human peripheral mononuclear and polymorphonuclear leukocyte functions. [1994.09]
Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef. [1994.02]
In vivo therapeutic efficacy of cefdinir (FK482), a new oral cephalosporin, against Staphylococcus aureus and Haemophilus influenzae in mouse infection models. [1994.01]
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines. [1992.08]
Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates. [1992.04]
[Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field] [1992.01]
[Pharmacokinetic studies on oral antibiotics in pediatrics. V. A pharmacokinetic study on cefdinir in pediatrics] [1992.01]
[Pharmacokinetics and clinical effects of cefdinir 10% fine granules in pediatrics] [1992.01]
[The influence of cefdinir on the intestinal bacterial flora] [1992.01]
[Pharmacokinetic, bacteriological and clinical studies on cefdinir fine granules in the field of pediatrics] [1991.10]
[Laboratory and clinical studies of cefdinir 5% and 10% fine granules in pediatric field] [1991.10]
[Laboratory and clinical studies on cefdinir (10% fine granules) in pediatric field] [1991.10]
[Pharmacokinetic, bacteriological and clinical evaluations of cefdinir 10% fine granules in pediatrics] [1991.10]
[Clinical studies of cefdinir in pediatric infections] [1991.10]
[A clinical study on cefdinir in pediatric field] [1991.10]
[A clinical study on cefdinir 10% granule in pediatrics] [1991.10]
[Clinical studies on 10% cefdinir granules in pediatric infections] [1991.10]
[Clinical evaluation of cefdinir 10% granules in children] [1991.10]
[Pharmacokinetic and clinical studies of cefdinir in the pediatric field. Pediatric Study Group of Cefdinir] [1991.10]
[Clinical investigation of cefdinir in the pediatric field] [1990.10]
[A clinical study on cefdinir in pediatrics] [1990.10]
[Pharmacokinetic and clinical studies on cefdinir fine granules in children] [1990.10]
[Pharmacokinetic and clinical studies of cefdinir in pediatric field] [1990.10]
[Pharmacokinetics and clinical effects of cefdinir 5% fine granules in pediatrics] [1990.10]
[Laboratory and clinical studies on cefdinir in pediatric field] [1990.08]
[Clinical study on cefdinir in pediatric field] [1990.08]
[Clinical evaluation of cefdinir in pediatric field] [1990.08]
[Clinical studies on cefdinir granules in pediatric field] [1990.08]
[Clinical evaluation of a new oral cephem, cefdinir, in children] [1990.08]
[A clinical evaluation of cefdinir in pediatric infections] [1990.08]
[Laboratory and clinical studies on cefdinir in pediatric field] [1990.08]
[Clinical studies on cefdinir in pediatric infections] [1990.08]
[Clinical and pharmacokinetic evaluation of cefdinir in children] [1990.08]
Other possibly related research studies
Estimation of the intervention effect in a non-randomized study with pre- and post-mismeasured binary responses. [2005.02.15]
Fungal biofilm formation on cochlear implant hardware after antibiotic-induced fungal overgrowth within the middle ear. [2004.08]
Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase. [2001.03]
|
